QualityStocksNewsBreaks – TransCode Therapeutics, Inc. (NASDAQ: RNAZ) Adjourns Special Meeting Due to Lack of Quorum
TransCode Therapeutics (NASDAQ: RNAZ) announced that its April 21 special meeting has been adjourned to May 2 at 9:30 a.m. Eastern after failing to meet the quorum requirement. Only 12.73% of eligible shares were represented, below the one-third threshold. The adjournment is intended to allow further proxy solicitation on two proposals: a reverse stock split authorization at a 1-for-10 to 1-for-40 ratio, and the potential for further adjournment if needed. Stockholders as of April 2 are encouraged to vote by May 1 at 11:59 p.m. Eastern through mail, phone, internet or during the virtual meeting. To view the full press…
